mTOR immunosuppression in HIV-positive liver transplant recipients

Transplantation. 2010 Nov 15;90(9):1039-40; author reply 1040. doi: 10.1097/TP.0b013e3181f44c1e.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Retroviral Agents / therapeutic use
  • Antiretroviral Therapy, Highly Active
  • HIV / genetics
  • HIV Seropositivity / complications*
  • HIV Seropositivity / drug therapy
  • HIV Seropositivity / immunology
  • Humans
  • Immunosuppression Therapy / methods*
  • Liver Transplantation / immunology*
  • RNA, Viral / genetics
  • TOR Serine-Threonine Kinases / therapeutic use*

Substances

  • Anti-Retroviral Agents
  • RNA, Viral
  • TOR Serine-Threonine Kinases